Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) Director Larry Jobe bought 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 19th. The stock was purchased at an average price of $4.20 per share, for a total transaction of $21,000.00. Following the acquisition, the director directly owned 67,197 shares in the company, valued at approximately $282,227.40. This trade represents a 8.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Mannatech Stock Performance
Shares of MTEX opened at $3.95 on Thursday. The company’s fifty day moving average price is $5.56 and its 200 day moving average price is $7.28. Mannatech, Incorporated has a one year low of $3.80 and a one year high of $12.45. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.09 and a quick ratio of 0.59. The company has a market capitalization of $7.62 million, a PE ratio of -0.59 and a beta of 0.61.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.49 earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%. The company had revenue of $24.92 million for the quarter.
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Featured Stories
- Five stocks we like better than Mannatech
- Freight Boom: The Hormuz Blockade Payday
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
